# FDA Inspection 1091073 - Hans Biomed Corporation - April 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/8be1bc1b-1a7a-4d3b-a3dd-255dc65b4cad
Source feed: FDA_Inspections

> FDA Inspection 1091073 for Hans Biomed Corporation on April 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091073
- Company Name: Hans Biomed Corporation
- Inspection Date: 2019-04-05
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1282278 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/787c4d50-6cdc-4aae-bfa1-ad7d16f5af80)
- [FDA Inspection 1216052 - 2023-08-25](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/c9aabe20-af7a-4aed-ab22-36696d9695f0)
- [FDA Inspection 966652 - 2016-03-31](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/e1f3a509-f207-4dcb-ab3e-2273cae164b8)
- [FDA Inspection 893493 - 2014-06-03](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/71eb81e7-74fa-480f-9d0d-b4cc52952bfb)
- [FDA Inspection 848720 - 2013-08-29](https://www.keypedia.com/records/fda_inspections/hans-biomed-corporation/0636a765-72cf-4395-a840-87675246f50a)

Company: https://www.keypedia.com/companies/hans-biomed-corporation/60abe6f2-149e-4591-8422-7edc574c65a7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d